Well, the company isn't showing any signs of panic as the SP plunges. You would think they are a government research laboratory. There appears to be a lot of (forced) selling on anticipation that we leave the ASX300, but really, does that change anything from a scientific or commercial standpoint? Not really. Only from an investment perspective.
I will be relieved when the ASX make their announcements, but I am far more frustrated by the delays in the phase 2 trial readouts with no explanations or revised updates from management which has now created an information vacuum for shareholders.
GLTAH
Starpharma goes into overdrive - Fear and Greed, page-28
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 372123 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 5042 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |